Retrospective cohort study to assess the increased risk of myelotoxicity due to the combined use of fluoropyrimidines and thiazides

Study identification

• EU PAS number:
  EUPAS1000000181
• Study ID:
  1000000181
• Official title and acronym:
  Retrospective cohort study to assess the increased risk of myelotoxicity due to the combined use of fluoropyrimidines and thiazides
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  Retrospective cohort study to assess the increased risk of myelotoxicity due to the combined use of fluoropyrimidines and thiazides.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Clinical Pharmacology Service, Puerta de Hierro-Majadahonda University Hospital (HUPHM)

Spain

Study timelines

Date when funding contract was signed

Planned: 21/03/2024

Actual: 21/03/2024

Study start date

Planned: 01/04/2024

Actual: 01/05/2024

Data analysis start date

Planned: 08/01/2025

Date of interim report, if expected

Planned: 15/01/2025

Date of final study report

Planned: 28/02/2025

Sources of funding

No external funding

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable